Clinical and histological resolution of a basal cell carcinoma in a patient undergoing concurrent treatment of B-cell lymphoma with systemic R-CHOP.
J Plast Reconstr Aesthet Surg
; 67(9): e223-5, 2014 Sep.
Article
em En
| MEDLINE
| ID: mdl-25052183
ABSTRACT
Surgical resection is the definitive treatment modality for basal cell carcinoma (BCC). However, not all patients may be suitable for surgery. We describe a patient with a BCC, which resolved clinically and histologically when he underwent systemic R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone) for treatment of a high grade B-cell lymphoma. Although topical and intra-lesional 5-fluorouracil (5-FU) has been used as an adjunct to treatment, more recent reports have illustrated the treatment of BCC with systemic 5-FU in combination with bleomycin and cisplatin. We postulate that the combination of cyclophosphamide and doxorubicin with rituximab and prednisolone, which has not been previously reported in the literature, contributed to remission in this case.
Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Carcinoma Basocelular
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Neoplasias Nasais
/
Linfoma de Células B
Limite:
Aged
/
Humans
/
Male
Idioma:
En
Revista:
J Plast Reconstr Aesthet Surg
Ano de publicação:
2014
Tipo de documento:
Article